Table 4.

Adjusted risk of VTE by the level of serum albumin in 732 patients with available data

Serum Albumin (g/dl)NPatients with VTEOdds Ratio95% Confidence IntervalP Valuea
Reference range ≥3.0b2191.00
2.8 to <3.06631.410.34, 5.870.64
2.6 to <2.87422.170.63, 7.460.22
2.4 to <2.67242.050.59, 7.120.26
2.2 to <2.47711.310.31, 5.620.72
2.0 to <2.28284.321.46, 12.770.01
<2.0142153.561.28, 9.880.02
<2.8 versus ≥2.8447/2852.531.17, 5.470.02
  • a Logistic regression model with incremental values of serum albumin, adjusted for age at biopsy, sex, 24-hour proteinuria (g/d), immunosuppressive therapy, and registry site.

  • b Logistic regression model with serum albumin as a dichotomous variable. The serum albumin cut-point of 2.8 g/dl was determined from the incremental model (by 0.2 g/dl) reported in this table, with threshold for effect noted for values <2.8 g/dl. Adjusted for age at biopsy, sex, 24-hour proteinuria (g/d), immunosuppressive therapy, and registry site.